Stockscreener 앱 받기
0.4646
4.21%
-0.0204
전일 마감가:
$0.485
열려 있는:
$0.47
하루 거래량:
278.54K
Relative Volume:
0.67
시가총액:
$26.85M
수익:
$3.10M
순이익/손실:
$-97.43M
주가수익비율:
-0.2581
EPS:
-1.8
순현금흐름:
$-94.38M
1주 성능:
-2.52%
1개월 성능:
-42.17%
6개월 성능:
-74.89%
1년 성능:
-87.34%
1일 변동 폭
$0.455
$0.51
1주일 범위
$0.4431
$0.67
52주 변동 폭
$0.4431
$4.4599
Omega Therapeutics Inc Stock (OMGA) Company Profile
명칭
Omega Therapeutics Inc
전화
(617) 949-4360
주소
140 FIRST STREET, SUITE 501, CAMBRIDGE
OMGA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OMGA
Omega Therapeutics Inc
|
0.4646 | 26.85M | 3.10M | -97.43M | -94.38M | -1.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.23 | 113.70B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
682.54 | 75.52B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
663.74 | 39.78B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.41 | 35.34B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
121.22 | 29.05B | 3.30B | -501.07M | 1.03B | -2.1146 |
Omega Therapeutics Inc Stock (OMGA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-15 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2024-06-18 | 개시 | Raymond James | Outperform |
| 2023-05-25 | 재개 | Jefferies | Buy |
| 2022-12-08 | 개시 | H.C. Wainwright | Buy |
| 2022-09-23 | 개시 | Chardan Capital Markets | Buy |
Omega Therapeutics Inc 주식(OMGA)의 최신 뉴스
Omega Therapeutics announces board reshuffle and new director - MSN
Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation - Financial Times
Omega Therapeutics stock hits 52-week low at $0.52 - MSN
Omega Therapeutics stock hits 52-week low at $0.52 By Investing.com - Investing.com Canada
Omega Therapeutics faces loan default notice - Investing.com
Omega Therapeutics faces loan default notice By Investing.com - Investing.com UK
Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace
Omega Therapeutics Announces Director Resignation - Investing.com
Omega Therapeutics Chair Resigns from Board of Directors - Defense World
Omega Therapeutics stock hits 52-week low at $0.74 - Investing.com India
Omega Therapeutics, Inc. Announces Resignation of Michelle C. Werner as Member of the Board of Directors and the Nominating and Corporate Governance Committee - Marketscreener.com
Omega Therapeutics Faces Leadership Change and Takeover Proposal - Yahoo Finance
Omega Therapeutics stock hits 52-week low at $0.74 By Investing.com - Investing.com Canada
Omega Therapeutics Inc (NASDAQ: OMGA) Down -65.47% This Year: What Is Going To Happen Next - Stocks Register
Omega Therapeutics, Inc. Announces Board and Committee Changes - Marketscreener.com
Omega Therapeutics announces board changes By Investing.com - Investing.com Nigeria
Omega Therapeutics announces board changes - Investing.com India
Omega Therapeutics Appoints New Director Ravi Mehrotra - TipRanks
2024’s Busiest Dealmakers: Novartis Laps The Field, While Lilly, Sanofi Keep Busy - Citeline News & Insights
Omega Therapeutics, Inc. (OMGA) Reports Q3 Loss, Tops Revenue Estimates - MSN
Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies - Quantisnow
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer – Company Announcement - Financial Times
Piper Sandler Lowers Omega Therapeutics (NASDAQ:OMGA) Price Target to $4.00 - Defense World
Omega Therapeutics Reports Third Quarter 2024 Results - TipRanks
Omega Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
Omega Therapeutics stock target cut, keeps Overweight on clinical updates By Investing.com - Investing.com Canada
Shares of Flagship-founded biotech fall as CEO departs - The Business Journals
Omega Therapeutics (NASDAQ:OMGA) Downgraded to Market Perform Rating by Raymond James - MarketBeat
Piper Sandler Issues Pessimistic Forecast for Omega Therapeutics (NASDAQ:OMGA) Stock Price - MarketBeat
Omega Therapeutics Inc (OMGA) Quarterly 10-Q Report - Quartzy
Omega Therapeutics Names Kaan Certel as CEO - MarketWatch
Omega Therapeutics Announces Successful Completion of Phase - GlobeNewswire
Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results - The Manila Times
Omega Therapeutics, Inc. Announces Chief Executive Officer Changes - Marketscreener.com
Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner - Financial Times
Omega Therapeutics (NASDAQ:OMGA) Stock Price Down 0.9%Should You Sell? - MarketBeat
Global Alopecia Treatment Market is Anticipated to Surpass ~USD 4 Billion by 2030 | DelveInsight - GlobeNewswire
Omega Therapeutics Inc (OMGA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
4.93%
자본화:
|
볼륨(24시간):